SEC Form 4 · accession 0001484729-26-000004
CalciMedica, Inc. · CALC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
A. Rachel Leheny
Officer — CHIEF EXECUTIVE OFFICER · Director · 10% Owner
Period of report
Jun 25, 2026
Accepted (ET)
Jun 29, 2026 · 8:45 am EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001534133
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 25, 2026 | A | 186,729 | $0.8033 | A | 317,655 | D | |
| Common Stock | holding | — | — | — | 3,500 | I | By Scheibler-Leheny Family Living Trust | |
| Common Stock | holding | — | — | — | 1,000 | I | By Spouse | |
| Common StockF2 | holding | — | — | — | 356,989 | I | By Valence Investments SPV IV, LLC | |
| Common StockF2 | holding | — | — | — | 66,228 | I | By Valence Investments SPV V, LLC | |
| Common StockF2 | holding | — | — | — | 316,109 | I | By Valence Investments SPV VI, LLC |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The securities were acquired from the Issuer pursuant to a Securities Purchase Agreement dated June 23, 2026, with a closing date of June 25, 2026. The Securities Purchase Agreement and the issuance of the securities thereunder was approved by an independent committee of the Issuer's Board of Directors.
- F2The Reporting Person, a co-founder and managing director of Valence Investments SPV IV, LLC ("Valence IV"), Valence Investments SPV V, LLC ("Valence V") and Valence Investments SPV VI, LLC (Valence VI), may be deemed to beneficially own the securities held by Valence IV, Valence V and Valence VI (the "Valence Securities"). The Reporting Person disclaims beneficial ownership of the Valence Securities except to the extent of her pecuniary interest therein.